Invention Grant
- Patent Title: Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
-
Application No.: US17573110Application Date: 2022-01-11
-
Publication No.: US11851697B2Publication Date: 2023-12-26
- Inventor: Faycal Touti , Wendy Winckler Adamovich , Sophie Cazanave , Mehar Cheema , Robert S. Langer
- Applicant: Glympse Bio, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Glympse Bio, Inc.
- Current Assignee: Glympse Bio, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/53
- IPC: G01N33/53 ; C12Q1/37 ; G01N21/64 ; G01N33/58 ; G01N33/573 ; G01N33/542
Abstract:
The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
Public/Granted literature
- US20220128546A1 EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT Public/Granted day:2022-04-28
Information query
IPC分类:
